Madhavan Balachandran - 17 Jun 2026 Form 4 Insider Report for uniQure N.V. (QURE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Jun 2026, 08:05:31 UTC
Prior SEC filing
17 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christian Klemt, Attorney-in-Fact

Key filing fact

Madhavan Balachandran filed Form 4 for uniQure N.V. (QURE) on 22 Jun 2026.

Key facts

  • This page summarizes Madhavan Balachandran's Form 4 filing for uniQure N.V. (QURE).
  • 7 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 22 Jun 2026, 08:05.

Change

  • Previous filing in this sequence was filed on 17 Jun 2026.
  • Current net transaction value: -$526,485.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001555508 Primary reporting owner

Balachandran Madhavan

Relationship
Director
Address
C/O UNIQURE N.V., PAASHEUVELWEG 25A, AMSTERDAM, NETHERLANDS
Signature
/s/ Christian Klemt, Attorney-in-Fact
Signature date
22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QURE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+5,295
Change %
+12%
Price
$31.71*
Shares after
48,549
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1
QURE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+6,390
Change %
+13%
Price
$19.39*
Shares after
54,939
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1
QURE transaction

Ordinary Shares

Sale

Transaction value
$249,289
Shares
-5,295
Change %
-9.6%
Price
$47.08
Shares after
49,644
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1, F2
QURE transaction

Ordinary Shares

Sale

Transaction value
$205,202
Shares
-4,700
Change %
-9.5%
Price
$43.66
Shares after
44,944
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1, F3
QURE transaction

Ordinary Shares

Sale

Transaction value
$71,994
Shares
-1,690
Change %
-3.8%
Price
$42.60
Shares after
43,254
Date
17 Jun 2026
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QURE transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-5,295
Change %
-100%
Price
$0.000000*
Shares after
0
Date
17 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
5,295
Exercise price
$31.71
Footnotes
F1, F5
QURE transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-6,390
Change %
-100%
Price
$0.000000*
Shares after
0
Date
17 Jun 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,390
Exercise price
$19.39
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

Footnote F5

The Stock Option vested in full on January 25, 2020.

Footnote F6

The Stock Option vested in full on January 26, 2019.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .